🟢 Painreform is trading 8.1% up in pre-market with no confirmed company-specific catalyst

Painreform is trading at $1.07, up +8.10%, with no confirmed company-specific announcement dated August 28, 2026 identified.

• The latest listed company news was a July 27, 2026 report about $10 million raised through an equity-line facility.
• An earnings report was scheduled for August 28, 2026, but results were unavailable in the reviewed coverage.
• The move remains an unconfirmed catalyst rather than a clearly attributable event.